Top Markets
#1 Derive Derive +30.93%
#2 Audiera Audiera +14.63%
#3 Cross Cross +11.38%
#4 The Bitcoin Bull The Bitcoin Bull +10.74%
#5 Palladium Network Palladium Network +9.37%
#6 Gama Token Gama Token +9.19%
#7 Biconomy Biconomy +9.00%
#8 Humanity Humanity +8.26%
#9 Geodnet Geodnet +7.98%
#10 Velvet Velvet +7.50%
Coin of the day
Derive Derive
Настройки
Язык
Pусский
Валюта
USD
Тема
Kazia Therapeutics Limited Kazia Therapeutics Limited

Kazia Therapeutics Limited

KZA
Ранг среди акций #35840
Kazia Therapeutics Limited is a biotechnology firm specializing in oncology,... Kazia Therapeutics Limited is a biotechnology firm specializing in oncology, committed to developing innovative therapies for cancer. Its flagship product candidate, Paxalisib, is a brain-penetrant small molecule that inhibits the PI3K/Akt/mTor pathway and is currently being investigated as a potential treatment for glioblastoma. Additionally, the company is progressing EVT801, an investigational new drug aimed at combating various types of cancer. Established in 1994 and headquartered in Sydney, Australia, the entity was formerly known as Novogen Limited before adopting the name Kazia Therapeutics Limited in November 2017.
Цена акции
$0.05207079
Последняя синхронизация: 2023-11-15
Рыночная капитализация
$3.38M
Изменение (1 день)
0.13%
Изменение (1 год)
0.00%
Страна
AU
Торговля Kazia Therapeutics Limited (KZA)

Категория

Healthcare
Коэффициент P/B для Kazia Therapeutics Limited (KZA)
Коэффициент P/B на 2026 TTM: 0
Согласно последним финансовым отчетам и цене акций Kazia Therapeutics Limited, текущий коэффициент P/B (TTM) составляет 0. В конце 2026 он составлял 0.
История P/B для Kazia Therapeutics Limited с 2026 по 2026
Коэффициент P/B в конце каждого года
Год P/B Изменить
Недостаточно данных для указанных дат.
Коэффициент P/B для аналогичных компаний или конкурентов
Компания P/B Разница P/B Страна
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.4612 -
BE